1,4-alpha-glucan-branching enzyme

BE0010808ProteinHumansGBE1

Glycogen-branching enzyme participates in the glycogen biosynthetic process along with glycogenin and glycogen synthase. It is acted on by 1 drug in DrugBank.

Gene name
GBE1
UniProtKB entry
Q04446Swiss-Prot
Residues / weight
702 residues · 80,473 Da
Also known as
2.4.1.18 · Brancher enzyme · Glycogen-branching enzyme

Resolves to

Protein
UniProtQ04446UniProt nameGLGB_HUMAN
Gene
HGNCHGNC:4180NCBI Gene2632GeneCardsGBE1
Pharmacology
KEGGhsa:2632
Structure
PDB4BZYPDB5CLTPDB5CLW
Drugs

What you can answer from here — as of October 31, 2023

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
1Clinical trialTrials of drugs acting on it, by phase and status
Sign in
3Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which approved drugs act on 1,4-alpha-glucan-branching enzyme, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In